1. Home
  2. CSCO vs NVO Comparison

CSCO vs NVO Comparison

Compare CSCO & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cisco Systems Inc. (DE)

CSCO

Cisco Systems Inc. (DE)

HOLD

Current Price

$77.05

Market Cap

335.1B

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$49.36

Market Cap

269.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSCO
NVO
Founded
1984
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.1B
269.6B
IPO Year
1990
N/A

Fundamental Metrics

Financial Performance
Metric
CSCO
NVO
Price
$77.05
$49.36
Analyst Decision
Buy
Hold
Analyst Count
16
10
Target Price
$88.00
$54.25
AVG Volume (30 Days)
27.4M
26.4M
Earning Date
02-11-2026
02-04-2026
Dividend Yield
2.13%
2.48%
EPS Growth
22.12
1.77
EPS
2.78
3.62
Revenue
$59,054,000,000.00
$48,588,245,669.00
Revenue This Year
$9.32
N/A
Revenue Next Year
$5.07
$4.39
P/E Ratio
$27.64
$13.69
Revenue Growth
9.00
6.43
52 Week Low
$52.11
$43.08
52 Week High
$88.19
$93.80

Technical Indicators

Market Signals
Indicator
CSCO
NVO
Relative Strength Index (RSI) 44.73 41.12
Support Level $73.42 $48.08
Resistance Level $88.19 $50.07
Average True Range (ATR) 2.54 2.08
MACD -0.57 -0.78
Stochastic Oscillator 23.23 33.02

Price Performance

Historical Comparison
CSCO
NVO

About CSCO Cisco Systems Inc. (DE)

Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff-25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: